An estimated 7.38 million treatments were waiting to be carried out in England at the end of September, up from 7.37 million at the end of August and the highest level since October 2025, according to the Press Association's summary of NHS England's monthly performance statistics. The list relates to 6.24 million patients, broadly unchanged month on month. NHS England published the September referral to treatment figures on 12 November 2026. On the same day, the Press Association reported that 65.8% of patients began hospital treatment within 18 weeks in September, up from 65.2% in August and above the 65% target the government and NHS England had set for March 2026, with a next target of 70% by March 2027. Accident and emergency departments in England recorded 2.50 million attendances in October, the first month on record above two and a half million, of whom 74.0% were seen within four hours.
Long waits, corridor care and cancer
An estimated 116,353 people had been waiting more than a year to start routine treatment at the end of September, up from 113,339 in August, per the Press Association summary. The number waiting more than 65 weeks rose from 10,782 to 12,825 and the number waiting more than 18 months from 1,637 to 2,015. Some 1.6% of people on the list had waited more than 52 weeks, against a target of under 1% set for March 2026. An average of 3,558 patients a day received corridor care in October, the highest since that data series began in May 2026. On cancer, 76.2% of urgently referred patients were diagnosed or had cancer ruled out within 28 days in September, down from 78.6% in August and below the 80% target.
What this means in practice
These are England-only figures. A national average says nothing about an individual wait, which turns on specialty, trust and clinical urgency, and the headline list moved by about 10,000 treatments in a month. The one-year group moved more, up around 3,000 in a month to 116,353 people. Nothing in these figures changes how food supplements are regulated or what any product does. Concerns about a referral or a symptom remain a question for a GP.
How Perqen members save
This is an NHS performance story rather than one about anything Perqen stocks, so there is no product link here. Membership costs £4.99 a month or £29.99 a year and unlocks member pricing across the full Perqen catalogue, on the terms set out on the Perqen membership page.
This article reports published news and research and is for information only. Food supplements are not a substitute for a varied diet or medical care, and no product mentioned is intended to diagnose, treat, cure or prevent any disease. Speak to your GP or pharmacist before changing what you take, especially if you are pregnant, breastfeeding, or taking prescribed medicines.
Sources
- Referral to treatment waiting times statistics for consultant-led elective care for September 2026 (NHS England, published 12 November 2026)
- Latest NHS hospital figures for England: key numbers and trends (Press Association, 12 November 2026)
- Referral to Treatment (RTT) Waiting Times (NHS England statistical work area)